There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (3)

Short Titles

Short Titles - House of Representatives

Short Title(s) as Introduced

SAVE Moms and Babies Act of 2019
Support And Value Expectant Moms and Babies Act of 2019

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To amend the Federal Food, Drug, and Cosmetic Act to prohibit the approval of new abortion drugs, to prohibit investigational use exemptions for abortion drugs, and to impose additional regulatory requirements with respect to previously approved abortion drugs, and for other purposes.

Actions Overview (1)

Date Actions Overview
09/19/2019Introduced in House

All Actions (3)

Date All Actions
09/20/2019Referred to the Subcommittee on Health.
Action By: Committee on Energy and Commerce
09/19/2019Referred to the House Committee on Energy and Commerce.
Action By: House of Representatives
09/19/2019Introduced in House
Action By: House of Representatives

Cosponsors (130)

* = Original cosponsor
CosponsorDate Cosponsored
Rep. Wagner, Ann [R-MO-2]* 09/19/2019
Rep. Norman, Ralph [R-SC-5]* 09/19/2019
Rep. Olson, Pete [R-TX-22]* 09/19/2019
Rep. Lamborn, Doug [R-CO-5]* 09/19/2019
Rep. Meadows, Mark [R-NC-11]* 09/19/2019
Rep. Allen, Rick W. [R-GA-12]* 09/19/2019
Rep. Williams, Roger [R-TX-25]* 09/19/2019
Rep. Smith, Christopher H. [R-NJ-4]* 09/19/2019
Rep. Weber, Randy K., Sr. [R-TX-14]* 09/19/2019
Rep. Watkins, Steve [R-KS-2]* 09/19/2019
Rep. Gianforte, Greg [R-MT-At Large]* 09/19/2019
Rep. Chabot, Steve [R-OH-1]* 09/19/2019
Rep. Babin, Brian [R-TX-36]* 09/19/2019
Rep. Ratcliffe, John [R-TX-4]* 09/19/2019
Rep. Loudermilk, Barry [R-GA-11]* 09/19/2019
Rep. Rutherford, John H. [R-FL-4]* 09/19/2019
Rep. LaMalfa, Doug [R-CA-1]* 09/19/2019
Rep. Flores, Bill [R-TX-17]* 09/19/2019
Rep. Hern, Kevin [R-OK-1]* 09/19/2019
Rep. Abraham, Ralph Lee [R-LA-5]* 09/19/2019
Rep. Harris, Andy [R-MD-1]* 09/19/2019
Rep. Hartzler, Vicky [R-MO-4]* 09/19/2019
Rep. Estes, Ron [R-KS-4]* 09/19/2019
Rep. Gibbs, Bob [R-OH-7]* 09/19/2019
Rep. Grothman, Glenn [R-WI-6]* 09/19/2019
Rep. Wittman, Robert J. [R-VA-1]* 09/19/2019
Rep. Foxx, Virginia [R-NC-5]* 09/19/2019
Rep. Walberg, Tim [R-MI-7]* 09/19/2019
Rep. Higgins, Clay [R-LA-3]* 09/19/2019
Rep. Mooney, Alexander X. [R-WV-2] 09/26/2019
Rep. Luetkemeyer, Blaine [R-MO-3] 09/26/2019
Rep. Banks, Jim [R-IN-3] 09/26/2019
Rep. Wright, Ron [R-TX-6] 09/26/2019
Rep. Collins, Chris [R-NY-27] 09/26/2019
Rep. Crawford, Eric A. "Rick" [R-AR-1] 09/26/2019
Rep. Gooden, Lance [R-TX-5] 09/27/2019
Rep. Mast, Brian J. [R-FL-18] 09/27/2019
Rep. Thompson, Glenn [R-PA-15] 10/15/2019
Rep. Jordan, Jim [R-OH-4] 10/15/2019
Rep. King, Steve [R-IA-4] 10/15/2019
Rep. Long, Billy [R-MO-7] 10/15/2019
Rep. Westerman, Bruce [R-AR-4] 10/15/2019
Rep. Baird, James R. [R-IN-4] 10/21/2019
Rep. Emmer, Tom [R-MN-6] 10/21/2019
Rep. Wenstrup, Brad R. [R-OH-2] 10/23/2019
Rep. Bucshon, Larry [R-IN-8] 10/28/2019
Rep. Gonzalez, Anthony [R-OH-16] 10/29/2019
Rep. Budd, Ted [R-NC-13] 10/29/2019
Rep. Gaetz, Matt [R-FL-1] 11/13/2019
Rep. Bishop, Rob [R-UT-1] 11/13/2019
Rep. Walker, Mark [R-NC-6] 11/13/2019
Rep. Wilson, Joe [R-SC-2] 11/13/2019
Rep. Moolenaar, John R. [R-MI-4] 11/13/2019
Rep. Biggs, Andy [R-AZ-5] 11/13/2019
Rep. Rooney, Francis [R-FL-19] 11/13/2019
Rep. Byrne, Bradley [R-AL-1] 11/13/2019
Rep. Comer, James [R-KY-1] 11/13/2019
Rep. Kelly, Mike [R-PA-16] 11/13/2019
Rep. Smith, Jason [R-MO-8] 11/13/2019
Rep. Buck, Ken [R-CO-4] 11/15/2019
Rep. Johnson, Dusty [R-SD-At Large] 11/15/2019
Rep. McMorris Rodgers, Cathy [R-WA-5] 11/15/2019
Rep. Keller, Fred [R-PA-12] 11/15/2019
Rep. Marshall, Roger W. [R-KS-1] 11/18/2019
Rep. Smith, Adrian [R-NE-3] 11/18/2019
Rep. Turner, Michael R. [R-OH-10] 11/18/2019
Rep. Dunn, Neal P. [R-FL-2] 11/18/2019
Rep. Murphy, Gregory [R-NC-3] 11/18/2019
Rep. Curtis, John R. [R-UT-3] 11/18/2019
Rep. Hice, Jody B. [R-GA-10] 11/18/2019
Rep. Brooks, Mo [R-AL-5] 11/18/2019
Rep. Fulcher, Russ [R-ID-1] 11/26/2019
Rep. Cline, Ben [R-VA-6] 11/26/2019
Rep. Lipinski, Daniel [D-IL-3] 11/26/2019
Rep. Johnson, Mike [R-LA-4] 11/26/2019
Rep. Rose, John W. [R-TN-6] 11/26/2019
Rep. Cloud, Michael [R-TX-27] 11/26/2019
Rep. Posey, Bill [R-FL-8] 11/26/2019
Rep. Scalise, Steve [R-LA-1] 11/26/2019
Rep. LaHood, Darin [R-IL-18] 12/03/2019
Rep. Bost, Mike [R-IL-12] 12/03/2019
Rep. Burgess, Michael C. [R-TX-26] 12/03/2019
Rep. Steil, Bryan [R-WI-1] 12/10/2019
Rep. Hudson, Richard [R-NC-8] 12/10/2019
Rep. Walorski, Jackie [R-IN-2] 12/18/2019
Rep. Graves, Tom [R-GA-14] 12/18/2019
Rep. Smucker, Lloyd [R-PA-11] 12/18/2019
Rep. Duncan, Jeff [R-SC-3] 12/18/2019
Rep. Carter, Earl L. "Buddy" [R-GA-1] 12/18/2019
Rep. McKinley, David B. [R-WV-1] 12/18/2019
Rep. Graves, Garret [R-LA-6] 12/18/2019
Rep. Kustoff, David [R-TN-8] 12/18/2019
Rep. McHenry, Patrick T. [R-NC-10] 12/18/2019
Rep. Waltz, Michael [R-FL-6] 12/18/2019
Rep. Huizenga, Bill [R-MI-2] 12/18/2019
Rep. Reschenthaler, Guy [R-PA-14] 12/18/2019
Rep. Arrington, Jodey C. [R-TX-19] 12/18/2019
Rep. Taylor, Van [R-TX-3] 12/18/2019
Rep. Steube, W. Gregory [R-FL-17] 12/19/2019
Rep. Crenshaw, Dan [R-TX-2] 12/19/2019
Rep. Gohmert, Louie [R-TX-1] 12/19/2019
Rep. Griffith, H. Morgan [R-VA-9] 12/19/2019
Rep. Conaway, K. Michael [R-TX-11] 12/19/2019
Rep. Stauber, Pete [R-MN-8] 12/19/2019
Rep. Mitchell, Paul [R-MI-10] 12/19/2019
Rep. Davis, Rodney [R-IL-13] 12/19/2019
Rep. Roy, Chip [R-TX-21] 12/30/2019
Rep. Hagedorn, Jim [R-MN-1] 12/30/2019
Rep. Lesko, Debbie [R-AZ-8] 12/30/2019
Rep. Mullin, Markwayne [R-OK-2] 12/30/2019
Rep. Spano, Ross [R-FL-15] 12/30/2019
Rep. Guest, Michael [R-MS-3] 12/30/2019
Rep. Bishop, Dan [R-NC-9] 01/02/2020
Rep. Green, Mark E. [R-TN-7] 01/09/2020
Rep. Gosar, Paul A. [R-AZ-4] 01/09/2020
Rep. McCarthy, Kevin [R-CA-23] 01/24/2020
Rep. Davidson, Warren [R-OH-8] 01/24/2020
Rep. Joyce, John [R-PA-13] 01/24/2020
Rep. Roe, David P. [R-TN-1] 01/24/2020
Rep. Palmer, Gary J. [R-AL-6] 02/27/2020
Rep. Graves, Sam [R-MO-6] 03/02/2020
Rep. Stefanik, Elise M. [R-NY-21] 05/15/2020
Rep. Yoho, Ted S. [R-FL-3] 06/15/2020
Rep. Cook, Paul [R-CA-8] 06/25/2020
Rep. Jacobs, Chris [R-NY-27] 09/22/2020
Rep. Collins, Doug [R-GA-9] 09/24/2020
Rep. Kelly, Trent [R-MS-1] 09/24/2020
Rep. Pence, Greg [R-IN-6] 09/24/2020
Rep. Bergman, Jack [R-MI-1] 10/02/2020
Rep. McCaul, Michael T. [R-TX-10] 12/18/2020

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Related Documents
House Energy and Commerce09/19/2019 Referred to
House Energy and Commerce Subcommittee on Health09/20/2019 Referred to

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.

Latest Summary (1)

There is one summary for H.R.4399. View summaries

Shown Here:
Introduced in House (09/19/2019)

Support And Value Expectant Moms and Babies Act of 2019 or the SAVE Moms and Babies Act of 2019

This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved.

Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner.

The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner to also act as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient.

The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)